Related Experiment Video
Updated: Jun 20, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Microbial-host interactions in inflammatory bowel diseases and experimental colitis
1Departments of Medicine, Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599, USA. rbs@med.unc.edu
Inflammatory bowel diseases (IBD) involve immune responses to gut bacteria in genetically susceptible individuals. Manipulating the gut microbiome with probiotics or antibiotics may treat IBD and prevent relapses.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), result from complex interactions between genetic predisposition and environmental factors.
- Genetic factors influencing IBD pathogenesis include impaired immune regulation, compromised mucosal barrier function, and defects in bacterial clearance.
- Commensal bacteria play a critical role, triggering inflammatory responses in susceptible hosts while promoting immune tolerance in healthy individuals.
Purpose of the Study:
- To elucidate the role of commensal bacteria and host immune responses in the development of IBD.
- To investigate the specific bacterial species and immune pathways involved in Crohn's disease and ulcerative colitis.
- To explore potential therapeutic strategies targeting the gut microbiome for IBD management.
Main Methods:
- Analysis of host-microbe interactions using molecular techniques to assess bacterial populations in IBD patients.
- Investigation of immune responses, including T helper cell activation (Th1 and Th17), in relation to specific bacterial stimuli.
- Examination of epithelial cell responses to bacterial invasion and metabolic products.
Main Results:
- Molecular analysis reveals altered bacterial populations in IBD, with decreased clostridial subsets and increased Enterobacteriaceae.
- Invasive commensal bacteria trigger Th1 and Th17 responses implicated in CD pathogenesis in genetically susceptible individuals.
- Bacterial metabolic products contribute to epithelial injury in UC by disrupting host metabolism or antioxidant defenses.
Conclusions:
- The balance of beneficial and detrimental gut bacteria is crucial for maintaining intestinal homeostasis versus promoting inflammation.
- Targeting the gut microbiome through interventions like antibiotics, probiotics, and prebiotics offers a promising avenue for treating and preventing IBD relapses.
- Specific bacterial factors, such as adherent/invasive Escherichia coli, are significantly associated with ileal CD.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

